Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HELEN-009: Dexamethasone-sparing antiemetic regimen for AC chemotherapy
NCT05242874Phase 3Completed
- Sponsor
- Henan Cancer Hospital
- Start
- Feb 2022
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in chemotherapy-induced nausea and vomiting (CINV), sponsored by Henan Cancer Hospital. Started Feb 2022; status: completed.
02
Drugs
dexamethasone
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT05242874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05242874.